Effects of Ticagrelor on the Clinical consequences of Angioplasty in Myocardial Infarction and Covid-19.d
- Conditions
- Myocardial Infarction.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
- Registration Number
- IRCT20220813055675N1
- Lead Sponsor
- Artesh University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Patients over 18 years of age who present with acute myocardial infarction.
Candidates for emergent coronary angioplasty ( Percutaneous coronary intervention )
Less than 24 hours have passed since the onset of chest pain symptoms.
are infected with the concomitant covid-19 disease (proved by CT Scan or PCR).
Lack of patient consent to perform coronary interventions or enter the study
Chronic and necessary use of any anti-coagulant drug by the patient
severe renal failure (GFR less than 30)
Severe heart failure (EF less than 30%)
Age under 18 years old
Pregnancy or suspected pregnancy
History of intracranial or intraspinal bleeding
Administration of any intravenous antiviral drug in the same admision
Severe liver failure
Past history of any malignancy or chemotherapy regimen
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiovascular Death. Timepoint: During the index admission, and after 1 month from hospital discharge. Method of measurement: Admission file and follow-up data.
- Secondary Outcome Measures
Name Time Method Stent Thrombosis. Timepoint: During index admission and 1 month after discharge. Method of measurement: Coronary Angiography.;Myocardial Infarction. Timepoint: During index admission and 1 month after discharge. Method of measurement: Troponin measurement and Electrocardiography.;Arterial O2 saturation. Timepoint: During the index admission. Method of measurement: Pulse-Oxymetry.